Posted On: May 17, 2013 by Gregory J. Brodzik

Judge Sleet construes claims in ANDA litigation

In Pfizer Inc. et al. v. Sandoz Inc., C.A. No. 12-654-GMS-MPT (D. Del. May 7, 2013), Chief Judge Gregory M. Sleet recently issued an order construing the following six disputed terms of U.S. Patent No. 8,026,276, which is alleged to cover a pharmaceutical that treats advanced renal cell carcinoma:

- “CCI-779”

- “w/v”

- “w/v of citric acid”

- “parenteral composition”

- “preparing”

- “combining”

Pfizer Inc. et al. v. Sandoz Inc., C.A. No. 12-654-GMS-MPT (D. Del. May, 7, 2013)